Revised SPCs: Strensiq (asfotase alfa) solution for injection (all strengths)

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
30 August 2019

Abstract

SPC updated to advise that lipoatrophy and lipohypertrophy, have been reported at injection sites after several months in patients treated with asfotase alfa in clinical trials. Patients are advised to follow proper injection technique and to rotate injection sites.